A summary of important themes in aging (Melanie Swan)
http://mariakonovalenko.wordpress.com/2010/12/16/melanie-swan-a-summary-of-important-themes-in-aging-research/
Some of us know Melanie via DIYgenomics, CureTogether, or others from her more transhumanist work.. here's something recent on gerontology and aging.
"""
Melanie Swan, MBA, is an Affiliate Scholar of the IEET – The
Institute for Ethics and Emerging Technologies. Ms. Swan is a science
generalist, hedge fund manager, and founder of citizen science
organization DIYgenomics. She serves as a researcher and advisor to
foundations, government agencies, corporations, and startups, and is
active in the community promoting science and technology. Her life
mission is to impact millions of people by facilitating the widespread
deployment of beneficial high-impact science and technology.
Melanie recently summarized some important themes in aging research that were discussed at the second Bay Area Aging Meeting:
Processes work in younger organisms but not in older organisms
A
common theme in aging is that processes function well in the first half
of an organism’s life, then break-down in the second half, particularly
the last 20% of the lifespan. In one example, visualizations and
animations were created from the 3D tissue-sectioning of the intestine
of young (4 days old) and old (20 days old) C. elegans. In the younger
worms, nuclei and cells were homogenous and regularly spaced over the
course of the intestine running down the length of the worm. In older
worms, nuclei disappeared (an initial 30 sometimes ultimately dropped
to 10), and the intestine became twisted and alternately shrunken and
convoluted due to DNA accumulation and bacterial build-up.
Metabolism and oxidation critically influence aging processes
Two
interesting talks concerned UCP2 (mitochondrial uncoupling protein 2)
an enzyme which reduces the rate of ATP synthesis and regulates
bioenergy balance. UCP2 and UCP3 have an important but not yet fully
understood role in regulating ROS (reactive oxygen species) and overall
metabolic function, possibly by allowing protons to enter the
mitochondria without oxidative phosphorylation. The mechanism was
explored in results that worm lifespan was extended by inserting
zebrafish UCP2 genes (not natively present in the worm).
Immune system becomes compromised in older organisms
Two
talks addressed the issue of immune system compromise. One team created
a predictive analysis that could be used to assess an individual’s
immune profile and potential response to vaccines by evaluating
demographics, chronic infection status, gene expression data, cytokine
levels, and cell subset function. Other work looked into the specific
mechanisms that may degrade immune systems in older organisms. SIRT1
(an enzyme related to cell regulation) levels decline with age. This
leads to the instable acetylation of transcription factor FoxP3 (a gene
involved in immune system response), which suppresses the immune system
by reducing regulatory T cell (Treg) differentiation to respond to
pathogens.
Systems-level understanding of aging processes
Many aging
processes are systemic in nature with complex branching pathways and
unclear causality. Research was presented regarding two areas: P53 is a
critical tumor suppressor protein controlling many processes related to
aging and cell maintenance: cell division, apoptosis, and senescence,
and is estimated to be mutated in 50% of cancers. Research suggested
that more clues for understanding the multifactorial p53 pathway could
come from SnoN, which may be an alternative mechanism for activating
p53 as part of cellular stress response. Neurodegenerative pathologies
such as Alzheimer’s disease remain unsolved problems in aging. For
example, it is not known if the amyloid beta plaques that arise are
causal, or a protection mechanism in response to other causal agents.
Some research looked at where amyloid beta is produced in cells,
finding that after the amyloid precursor protein (APP) leaves the
endosome, both the Golgi and a related recycling complex may be related
in the generation of amyloid beta.
Lack of conservation progressing up the model organism chain
Aging
and other biological processes become more complicated with progression
up the chain of model organisms. What works in yeast and worms may not
work in mice, and what works in mice and rats may not work in humans.
Some interesting research looked at ribosomal proteins, whose deletion
is known to extend lifespan in model organisms. The key points were
first that there was fairly little (perhaps less than 20%) overlap in
lifespan-extending ribosomal protein deletions conserved between yeast
and worms. Second, an examination of some of the shared deletions in
mice (especially RPL19, 22, and 29) found some conservation (e.g.;
RPL29), and also underlined the systemic-nature of biology, finding
that other homologous genes (e.g.; RPL22L) may compensate for the
deletion, and thereby not extend lifespan.
Trade-offs is a key dynamic of aging processes
The idea of
trade-offs is another common theme in aging; the trade-offs between
processes, resource consumption, and selection. Exemplar of this was
research showing that the deletion of a single gene involved in lipid
synthesis, DGAT1, is beneficial and promotes longevity in mice when
calories are abundant, but is also crucial for survival in calorie
restricted situations. This supports the use of directed methylation to
turn genes on and off in different situations. More details were
presented in a second area of trade-offs: reproduction-lifespan. It is
known that reproduction is costly and organisms without reproductive
mechanisms may have extended lifespans. Research examined the specific
pathways, finding that Wnt and steroid hormone signaling in germline
and somatic reproductive tissues influenced worm longevity,
particularly through non-canonical (e.g.; not the usual) pathways by
involving signaling components MOM-2/Wnt and WRM-1/beta-catenin.
My conclusion: I have to say that I understand the Systems-level
biology of aging differently. Basically, it’s integrating the existing
knowledge in all the aspects of aging into a single system,
computational, visual or some other kind of system. Therefore, I would
certainly add the necessity of creating such an integrated system to
this list of goals / problems.
In general, it is clear that more research is needed in each of the
listed areas, as well as the set of established biomarkers in order to
translate the findings from model animals to humans. The problem of
biomarkers brings us back to the systems biology of aging.
"""
- Bryan
http://heybryan.org/1 512 203 0507